J
Joseph L. Izzo
Researcher at University at Buffalo
Publications - 232
Citations - 53804
Joseph L. Izzo is an academic researcher from University at Buffalo. The author has contributed to research in topics: Blood pressure & Systolic hypertension. The author has an hindex of 46, co-authored 229 publications receiving 51755 citations. Previous affiliations of Joseph L. Izzo include Erie County Medical Center & LSU Health Sciences Center New Orleans.
Papers
More filters
Journal ArticleDOI
Reduction in human urinary MHPG excretion by guanethidine: Urinary MHPG as index of sympathetic nervous activity
TL;DR: The norepinephrine metabolites methoxyhydroxyphenyl glycol (MHPG) and vanillylmandelic acid (VMA) were measured in the urine of hypertensive subjects before and during adminstration of guanethidine, a peripheral sympatholytic agent which does not cross the blood-brain barrier or deplete adrenal catecholamines.
Journal ArticleDOI
Titration of HCTZ to 50 mg Daily in Individuals With Stage 2 Systolic Hypertension Pretreated With an Angiotensin Receptor Blocker
TL;DR: Compared with OM 40 mg/d monotherapy, neither dose of HCTZ affected serum potassium, but both increased serum glucose by about 5%.
Journal ArticleDOI
Transluminal recanalization of an occluded renal artery: reversal of anuria in a patient with a solitary kidney.
TL;DR: The reversal of anuria by percutaneous transluminal recanalization of a recently occluded renal artery in a patient with a single functioning kidney is reported.
Journal ArticleDOI
Predictors for the development of microalbuminuria and interaction with renal function
Christos Chatzikyrkou,Jan Menne,Joseph L. Izzo,Giancarlo Viberti,Ton J. Rabelink,Luis M. Ruilope,Christian Rump,Peter R. Mertens,Hermann Haller +8 more
TL;DR: Predictors of new onset microalbuminuria are the classical cardiovascular risk factors, followed by age, weight, glycosylated hemoglobin type A1C, blood glucose, total cholesterol, SBP number of antihypertensive drugs and heart rate.
Journal ArticleDOI
Protamine zinc insulin modified for accelerated action
Arthur R. Colwell,Joseph L. Izzo +1 more
TL;DR: In the routine treatment of diabetes mellitus it is often necessary to use simultaneously two types of insulin with different timing and intensity qualities of action, and protamine zinc insulin in dosage low enough to avoid hypoglycemia between meals or at night usually permits glycosuria after meals.